NCI Symposium on Translational Technologies for Global Health

Celebrate ten years of NCI funding projects in the Affordable Cancer Technologies (ACTs) Program at the upcoming NCI Symposium on Translational Technologies for Global Health. This two-day conference aims to bring together a diverse range of experts, including cancer researchers and technology developers, to accelerate global health technology innovation, validation, and commercialization in the field of oncology.

During this conference, you’ll hear about:

• resource-appropriate, translational technology research and development for cancer in an affordable, low-resource setting.
• clinical implementation studies and real-world health settings in low- and middle-income countries.
• innovations in technology for global oncology.
• accelerating global health technology innovation, validation, and commercialization through artificial intelligence.

The ACTs Program has supported resource-appropriate translational technology research and development for cancer while ensuring affordability and potential impact in low-resource settings as essential design components. The ACTs Program sees technology through every stage, from prototype to clinical implementation studies. Low- and middle-income countries validate the technologies in real-world health settings, leading to additional innovations.